Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oxycodone controlled release - Purdue Pharma

Next Previous
X
Search
Drug Profile

Oxycodone controlled release - Purdue Pharma

Alternative Names: OxiContin; Oxycodone controlled release - Purdue; Oxycodone extended release - Purdue; Oxycodone hydrochloride controlled-release; OxyContin; OxyContin Neo; OxyContinTR; OxyNeo

Latest Information Update: 04 Jan 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Purdue Pharma
  • Developer Mundipharma International; Napp Pharmaceutical Group; Purdue Pharma; Shionogi
  • Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer pain; Pain; Postoperative pain

Most Recent Events

  • 04 Jan 2024 Discontinued - Phase-III for Pain (In children) in Greece (PO)
  • 04 Jan 2024 Discontinued - Phase-III for Pain (In children) in Hungary (PO)
  • 04 Jan 2024 Discontinued - Phase-III for Pain (In children) in Israel (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top